Key result
Ventricular tachycardia in an 18-month-old infant was successfully controlled using a massive dose of procainamide, achieving a therapeutic plasma level of /ml.
Why the study?
Does massive dose procainamide control ventricular tachycardia in an infant?
Case Report (n=1)
Does massive dose procainamide control ventricular tachycardia in an infant?
Answers are grounded in this paper and cite their sources.
Massive doses of procainamide may be required to achieve therapeutic plasma levels and control ventricular tachycardia in infants, possibly due to altered pharmacokinetics.
An 18-month-old infant presented with ventricular tachycardia. The arrhythmia was controlled only with procaineamide in a dose of 3,600 mg/day. A plasma procaineamide level was 9 µg/ml which is within the therapeutic range previously described for adults. Poor absorption, increased tolerance of the agent, and a large volume of distribution relative to body weight may account for the high dosage required. No etiology for the arrhythmia was found and the child made an uneventful recovery. The pharmacological effects of procaineamide on cardiac electrophysiology are discussed.
No takes yet. Share an insight, caveat, or question.
Gelband et al. (1971) conducted a case report in Ventricular tachycardia (n=1). Procainamide was evaluated on Arrhythmia control. Ventricular tachycardia in an 18-month-old infant was successfully controlled using a massive dose of procainamide, achieving a therapeutic plasma level of /ml.
Synapse has enriched 10 related papers. Consider them for comparative context: